Key result
ADAR1 is an essential RNA editing enzyme involved in immune responses and hematopoiesis, with its dysregulation linked to diseases ranging from cancers to neurological abnormalities.
Understanding ADAR1's role in RNA editing and its disease-specific patterns may offer novel diagnostic and prognostic insights across various human diseases.
Answers are grounded in this paper and cite their sources.
ADAR1 dysregulation warrants no practice change; leaves open hypothesis-generating roles in cancer and neurological diagnostics.
Adenosine deaminases acting on RNA (ADARs) convert adenosine to inosine in double-stranded RNA (dsRNA). Among the three types of mammalian ADARs, ADAR1 has long been recognized as an essential enzyme for normal development. The interferon-inducible ADAR1p150 is involved in immune responses to both exogenous and endogenous triggers, whereas the functions of the constitutively expressed ADAR1p110 are variable. Recent findings that ADAR1 is involved in the recognition of self versus non-self dsRNA provide potential explanations for its links to hematopoiesis, type I interferonopathies, and viral infections. Editing in both coding and noncoding sequences results in diseases ranging from cancers to neurological abnormalities. Furthermore, editing of noncoding sequences, like microRNAs, can regulate protein expression, while editing of Alu sequences can affect translational efficiency and editing of proximal sequences. Novel identifications of long noncoding RNA and retrotransposons as editing targets further expand the effects of A-to-I editing. Besides editing, ADAR1 also interacts with other dsRNA-binding proteins in editing-independent manners. Elucidating the disease-specific patterns of editing and/or ADAR1 expression may be useful in making diagnoses and prognoses. In this review, we relate the mechanisms of ADAR1's actions to its pathological implications, and suggest possible mechanisms for the unexplained associations between ADAR1 and human diseases.
No takes yet. Share an insight, caveat, or question.
Song et al. (2016) conducted a review in Human diseases. ADAR1 was evaluated. ADAR1 is an essential RNA editing enzyme involved in immune responses and hematopoiesis, with its dysregulation linked to diseases ranging from cancers to neurological abnormalities.
Synapse has enriched 10 related papers. Consider them for comparative context: